VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
1. 系统已在2025-11-20 17:39:31对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s2468-1253(24)00237-1
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2468125324002371
其他信息:
出版社: Elsevier BV
作者: Man-Fung Yuen; Young-Suk Lim; Ki Tae Yoon; Tien-Huey Lim; Jeong Heo; Pisit Tangkijvanich; Won Young Tak; Vaidehi Thanawala; Daniel Cloutier; Shenghua Mao; Andre Arizpe; Andrea L Cathcart; Sneha V Gupta; Carey Hwang; Edward Gane

